2m 2m 2m 2m 2m 2m 2m
EDGEWISE THERAP (EWTX)
NASDAQ
$41.40+$0.92 (+2.27%)
Price as of Oct 02, 2026 6:07 PM EDT- $4.4BMarket Cap
- 169.87%1-Year Change
- BiotechnologyIndustry
EDGEWISE THERAP (EWTX)
$41.40+$0.92 (+2.27%)
EWTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.48 | ||
Change | -$0.12 (-0.30%) | ||
Open | $40.39 | ||
High | $41.46 | ||
Low | $39.86 | ||
Previous Close | $40.60 | ||
Volume | 1,286,683 | ||
30-Day Average Volume | 1,636,095 | ||
1-Week Change | -1.65% | ||
1-Month Change | -4.19% | ||
1-Year Change | 169.87% | ||
3-Year Change | 606.46% | ||
5-Year Change | 130.79% | ||
Fundamentals | |||
Shares Outstanding | 108.6M | ||
Total Assets | $479.7M | ||
Market Cap | $4.4B | ||
Enterprise Value | $4.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$57.3M | ||
Free Cash Flow | -$42.5M | ||
EBIT | -$57.3M | ||
EBITDA | -$56.8M | ||
Net Working Capital | $442.5M | ||
EPS | -$0.53 | ||
Enterprise Value/EBITDA | -76 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -76 | ||
PEG | 5 | ||
Price/Free Cash Flow | -103 | ||
Price/Operating Cash Flow | -104 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue